Lightening in a vial people!!! 7 reasons that can't be denied for $45 Price Target
Lightening in a vial people!!! It amuses me how so many retail investors get the deer in the headlights reaction to these things.
01. The medicine is FDA approved for 19 indications.
02. Doctors prescribe this medicine because primary medicine is not working for the patient.
03. The SEC is only investigating promotional marketing issues. Small fine will close that up.
04. Q over Q revenue is growing.
05. Shares outstanding is very low vs revenue.
06. Aetna will pay once they are challenged by a Doctors rx.
07. Big pharma would pay big to have this revenue stream under their wing.
I see nothing but good things coming out of this because the medicine works wonders.